This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNDQP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a prescription medication. The fixed-price contract has a ceiling value of $1,183.44 and an ultimate completion date of December 20, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying this pharmaceutical product to support federal healthcare programs, particularly within the military and veterans' healthcare systems. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense.
Generated 3/20/25, 10:43 AM